can the pharmaceutical industry restore its broken image? /
نام نخستين پديدآور
John L. LaMattina, Ph.D
مشخصات ظاهری
نام خاص و کميت اثر
ix, 125 pages :
ساير جزييات
illustrations ;
ابعاد
25 cm
يادداشت کلی
متن يادداشت
Chapter 1. The four secrets that drug companies don't want you to know -- Chapter 2. What has happened to R&D productivity? -- Chapter 3. Callenges in key therapeutic areas for improving --Chapter 4. Improving R&D output -- Chapter 5. Restoring pharma's image -- Chapter 6. Final thoughts
یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references and index
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
"While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former Pfizer president John LaMattina, this book addresses the progress that the industry has made in improving its abilities to measure both the risk and benefits of its new medicines, where the industry should invest its R&D resources, and how the industry can rehabilitate its image. Essential reading for pharmaceutical executives and professionals"--
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Pharmaceutical industry-- Corrupt practices
رده بندی ديویی
شماره
338
.
4/76151
ويراست
23
رده بندی کنگره
شماره رده
HD9665
.
5
نشانه اثر
.
L36
2013
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )